Biotechnology and Bioengineering, 114 (1), 106-112
It claimed 'GLP-1s for diabetes could be sold at a profit for just US $0.89 per month, compared to the price of $95 per month charged in Brazil, $115 per month charged in South Africa, $230 charged in Latvia and $353 charged in the US, which is a 39,562% markup over what the estimated generic price could be.' Christa Cepuch, Pharmacist Coordinator at MSF's Access Campaign, argues 'These new drugs are an absolute game changer for people living with diabetes, but are being kept out of the hands of hundreds of millions of people in low- and middle-income countries who need them' (Barber, Gotham, Bygrave
Benefits: Significant Weight Loss: Studies consistently demonstrate substantial weight reduction with semaglutide use
Rapid weight loss can stress joints, connective tissue, and muscle
Such a fluctuation can significantly disrupt GLP-1 levels
Research has shown that semaglutide leads to major weight loss